• 579 Citations
  • 11 h-Index
1992 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1992 2019

  • 579 Citations
  • 11 h-Index
  • 32 Article
2019
2 Citations (Scopus)

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Gamucci, T., Pizzuti, L., Natoli, C., Mentuccia, L., Sperduti, I., Barba, M., Sergi, D., Iezzi, L., Maugeri-Saccà, M., Vaccaro, A., Magnolfi, E., Gelibter, A., Barchiesi, G., Magri, V., D’Onofrio, L., Cassano, A., Rossi, E., Botticelli, A., Moscetti, L., Omarini, C. & 29 others, Fabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Mazzotta, M., Bria, E., Foglietta, J., Samaritani, R., Garufi, C., Mariani, L., Barni, S., Mirabelli, R., Sarmiento, R., Graziano, V., Santini, D., Marchetti, P., Tonini, G., Di Lauro, L., Sanguineti, G., Paoletti, G., Tomao, S., De Maria, R., Veltri, E., Paris, I., Giotta, F., Latorre, A., Giordano, A., Ciliberto, G. & Vici, P., Feb 1 2019, In : Cancer Biology and Therapy. 20, 2, p. 192-200 9 p.

Research output: Contribution to journalArticle

Taxoids
Observational Studies
Retrospective Studies
Breast Neoplasms
Maintenance
2018
11 Citations (Scopus)
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A. & 209 others, Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F., Accurso, A., Agostara, B., Aieta, M., Alabiso, O., Alicicco, M. G., Amadori, D., Amaducci, L., Amiconi, G., Antuzzi, G., Ardine, M., Ardizzoia, A., Aversa, C., Badalamenti, G., Barni, S., Basurto, C., Berardi, R., Bergamasco, C., Bidoli, P., Bighin, C., Biondi, E., Bisagni, G., Boni, C., Borgonovo, K., Botta, M., Bravi, S., Bruzzi, P., Buono, G., Butera, A., Caldara, A., Candeloro, G., Cappelletti, C., Cardalesi, C., Carfora, E., Cariello, A., Carrozza, F., Cartenì, G., Caruso, M., Casadei, V., Casanova, C., Castori, L., Cavanna, L., Cavazzini, G., Cazzaniga, M., Chilelli, M., Chiodini, P., Chiorrini, S., Ciardiello, F., Ciccarese, M., Cinieri, S., Clerico, M., Coccaro, M., Comande, M., Corbo, C., Cortino, G., Cusenza, S., Daniele, G., D'arco, A. M., D'auria, G., Dazzi, C., De Angelis, C., de Braud, F., De Feo, G., De Matteis, A., De Tursi, M., Di Blasio, A., di Lucca, G., Di Lullo, L., Di Rella, F., Di Renzo, G., Di Stefano, P., Di Stefano, A., Diana, A., Donati, S., Fabbri, A., Fabi, A., Faedi, M., Farina, G., Farris, A., Febbraro, A., Fedele, P., Federico, P., Ferraù, F., Ferretti, G., Ferro, A., Floriani, I., Forcignanò, R., Forciniti, S., Forestieri, V., Fornari, G., Frisinghelli, M., Fusco, V., Gallizzi, G., Galvano, A., Gambardella, A., Gambi, A., Gebbia, V., Gervasi, E., Ghilardi, M., Giacobino, A., Giardina, G., Giotta, F., Giraudi, S., Giuliano, M., Grassadonia, A., Grasso, D., Grosso, F., Guizzaro, L., Incoronato, P., Incorvaia, L., Iodice, G., La Verde, N., Labonia, V., Landi, G., Latorre, A., Leonardi, V., Levaggi, A., Limite, G., Lina Bascialla, L., Livi, L., Maiello, E., Mandelli, D., Marcon, I., Menon, D., Montedoro, M., Moraca, L., Moretti, A., Morritti, M. G., Morselli, P., Mura, A., Mura, S., Musacchio, M., Muzio, A., Natale, D., Natoli, C., Nigro, C., Nisticò, C., Nuzzo, A., Orditura, M., Orlando, L., Pacilio, C., Palumbo, G., Palumbo, R., Pasini, F., Paterno, E., Pazzola, A., Pelliccioni, S., Pensabene, M., Perroni, D., Pesenti Gritti, A., Petrelli, F., Piccirillo, M. C., Pinotti, G., Pogliani, C., Poli, D., Prader, S., Recchia, F., Rizzi, D., Romano, C., Rossello, R., Rossini, C., Salvucci, G., Sanna, V., Santini, A., Saracchini, S., Savastano, C., Scambia, G., Schettini, F., Schiavone, P., Schirone, A., Seles, E., Signoriello, S., Signoriello, G., Silva, R. R., Silvestri, A., Simeon, V., Spagnoletti, I., Tamberi, S., Teragni, C., Thalmann, V., Thomas, R., Thomas, G., Tienghi, A., Tinari, N., Tinessa, V., Tomei, F., Tonini, G., Torri, V., Traficante, D., Tudini, M., Turazza, M., Vignoli, R., Vitale, M. G., Zacchia, A., Zagarese, P., Zanni, A., Zavallone, L., Zavettieri, M., Zoboli, A. & Investigators, GIM., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

Leo, S., Arnoldi, E., Repetto, L., Coccorullo, Z., Cinieri, S., Fedele, M., Cazzaniga, M., Lorusso, V., Latorre, A., Campanella, G., Ciccarese, M., Accettura, C., Pisconti, S., Rinaldi, A., Brunetti, C., Raffaele, M., Coltelli, L., Spazzapan, S., Fratino, L., Petrucelli, L. & 1 others, Biganzoli, L., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

eribulin
Geriatrics
Observational Studies
Geriatric Assessment
Breast Neoplasms
2017
2 Citations (Scopus)

Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience

Ciccarese, M., Fabi, A., Moscetti, L., Cazzaniga, M. E., Petrucelli, L., Forcignanò, R., Lupo, L. I., De Matteis, E., Chiuri, V. E., Cairo, G., Febbraro, A., Giordano, G., Giampaglia, M., Bilancia, D., La Verde, N., Maiello, E., Morritti, M., Giotta, F., Lorusso, V., Latorre, A. & 5 others, Scavelli, C., Romito, S., Cusmai, A., Palmiotti, G. & Surico, G., Jun 1 2017, In : Breast Cancer Research and Treatment. 163, 3, p. 587-594 8 p.

Research output: Contribution to journalArticle

exemestane
Stomatitis
Hormones
Breast Neoplasms
Population
7 Citations (Scopus)

Efficacy and safety of eribulin in taxane-refractory patients in the 'real world'

Lorusso, V., Cinieri, S., Latorre, A., Porcu, L., Del Mastro, L., Puglisi, F. & Barni, S., May 1 2017, In : Future Oncology. 13, 11, p. 971-978 8 p.

Research output: Contribution to journalArticle

eribulin
Safety
Breast Neoplasms
Asthenia
Neutropenia
2016
6 Citations (Scopus)

Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study

Arpino, G., Michelotti, A., Truini, M., Montemurro, F., Russo, S., Palumbo, R., Zamagni, C., Latorre, A., Bruzzese, D., Riccardi, F., De Laurentiis, M., Beano, A., Biganzoli, L., Zaniboni, A., Laudadio, L., Malagoli, M., Bilancia, D., Schettini, F., Giuliano, M., Cazzaniga, M. E. & 1 others, De Placido, S., Mar 1 2016, In : Journal of Cancer Research and Clinical Oncology. 142, 3, p. 669-678 10 p.

Research output: Contribution to journalArticle

Demography
Clinical Trials
Prospective Studies
Breast Neoplasms
Randomized Controlled Trials

Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study

Arpino, G., Michelotti, A., Truini, M., Montemurro, F., Russo, S., Palumbo, R., Zamagni, C., Latorre, A. C., Bruzzese, D., Riccardi, F., De Laurentiis, M., Beano, A., Biganzoli, L., Zaniboni, A., Laudadio, L., Malagoli, M., Bilancia, D., Schettini, F., Giuliano, M., Cazzaniga, M. & 1 others, De Placido, S., Mar 1 2016, In : Journal of Cancer Research and Clinical Oncology. 142, 3, p. 669-678 10 p.

Research output: Contribution to journalArticle

Demography
Clinical Trials
Prospective Studies
Breast Neoplasms
Randomized Controlled Trials

Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study

Arpino, G., Michelotti, A., Truini, M., Montemurro, F., Russo, S., Palumbo, R., Zamagni, C., Latorre, A. C., Bruzzese, D., Riccardi, F., De Laurentiis, M., Beano, A., Biganzoli, L., Zaniboni, A., Laudadio, L., Malagoli, M., Bilancia, D., Schettini, F., Giuliano, M., Cazzaniga, M. & 1 others, De Placido, S., Mar 1 2016, In : Journal of Cancer Research and Clinical Oncology. 142, 3, p. 669-678 10 p.

Research output: Contribution to journalArticle

Demography
Clinical Trials
Prospective Studies
Breast Neoplasms
Randomized Controlled Trials
4 Citations (Scopus)

FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics

Petroni, S., Caldarola, L., Scamarcio, R., Giotta, F., Latorre, A., Mangia, A. & Simone, G., Nov 1 2016, In : Oncology Letters. 12, 5, p. 3115-3122 8 p.

Research output: Contribution to journalArticle

Fluorescence In Situ Hybridization
Immunohistochemistry
Breast Neoplasms
Ductal Carcinoma
Gene Amplification
2013

Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement

Giotta, F., Latorre, A., Cramarossa, A., Simone, G., Florio, C., Oliva, S. & Lorusso, V., Nov 2013, In : Tumori. 99, 6

Research output: Contribution to journalArticle

Breast Neoplasms
Liver
Neoplasms
Progesterone Receptors
Therapeutics
2011
5 Citations (Scopus)
docetaxel
gemcitabine
Confidence Intervals
Breast Neoplasms
Therapeutics
20 Citations (Scopus)
Epirubicin
Anthracyclines
Breast Neoplasms
Disease-Free Survival
Therapeutics
2007
117 Citations (Scopus)

Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of β-tubulins

Tommasi, S., Mangia, A., Lacalamita, R., Bellizzi, A., Fedele, V., Chiriatti, A., Thomssen, C., Kendzierski, N., Latorre, A., Lorusso, V., Schittulli, F., Zito, F., Kavallaris, M. & Paradiso, A., May 15 2007, In : International Journal of Cancer. 120, 10, p. 2078-2085 8 p.

Research output: Contribution to journalArticle

Tubulin
Paclitaxel
Cytoskeleton
Breast Neoplasms
MHC Class I Genes
15 Citations (Scopus)

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: A phase II multicentric study

Giotta, F., Lorusso, V., Maiello, E., Filippelli, G., Valerio, M. R., Caruso, M., Verderame, F., Latorre, A. & Colucci, G., Jun 2007, In : Annals of Oncology. 18, SUPPL. 6

Research output: Contribution to journalArticle

Cyclophosphamide
Breast Neoplasms
Therapeutics
Doxorubicin
liposomal doxorubicin
2006
26 Citations (Scopus)

Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale)

Lorusso, V., Spada, M., Giampaglia, M., Misino, A., Calabrese, R., Latorre, A., Monticelli, G., Guida, M., Sambiasi, D. & Colucci, G., Jun 2006, In : Annals of Oncology. 17, SUPPL. 7

Research output: Contribution to journalArticle

Breast Neoplasms
Capecitabine
vinorelbine
Hand-Foot Syndrome
Taxoids
2005
113 Citations (Scopus)

Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer

Paradiso, A., Mangia, A., Chiriatti, A., Tommasi, S., Zito, A., Latorre, A., Schittulli, F. & Lorusso, V., May 2005, In : Annals of Oncology. 16, SUPPL. 4

Research output: Contribution to journalArticle

Tubulin
Paclitaxel
Biomarkers
Breast Neoplasms
Drug Therapy
2003
9 Citations (Scopus)

Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin

Catino, A., Crucitta, E., Latorre, A., Sambiasi, D., Calabrese, P. & Lorusso, V., Jan 2003, In : Oncology Reports. 10, 1, p. 163-167 5 p.

Research output: Contribution to journalArticle

Amifostine
Doxorubicin
Breast Neoplasms
Organoplatinum Compounds
Taxoids
21 Citations (Scopus)

A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer

Lorusso, V., Crucitta, E., Silvestris, N., Guida, M., Misino, A., Latorre, A. & De Lena, M., 2003, In : Clinical Breast Cancer. 4, 2, p. 138-141 4 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Maximum Tolerated Dose
Taxoids
Neutropenia
Capecitabine
7 Citations (Scopus)

Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

Lorusso, V., Crucitta, E., Silvestris, N., Catino, A., Caporusso, L., Mazzei, A., Guida, M., Latorre, A., Sambiasi, D., D'Amico, C., Schittulli, F., Calabrese, P. & De Lena, M., Feb 24 2003, In : British Journal of Cancer. 88, 4, p. 491-495 5 p.

Research output: Contribution to journalArticle

gemcitabine
Mitoxantrone
Breast Neoplasms
Drug Therapy
Neutropenia
2002
34 Citations (Scopus)

Epithelial ovarian cancer: second and third line chemotherapy (review).

Latorre, A., De Lena, M., Catino, A., Crucitta, E., Sambiasi, D., Guida, M., Misino, A. & Lorusso, V., Jul 2002, In : International Journal of Oncology. 21, 1

Research output: Contribution to journalArticle

Platinum
Drug Therapy
oxaliplatin
gemcitabine
Ovarian Neoplasms
2001
98 Citations (Scopus)

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

De Lena, M., Lorusso, V., Latorre, A., Fanizza, G., Gargano, G., Caporusso, L., Guida, M., Catino, A., Crucitta, E., Sambiasi, D. & Mazzei, A., 2001, In : European Journal of Cancer. 37, 3, p. 364-368 5 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Cisplatin
Paclitaxel
Confidence Intervals
Drug Therapy
2000
4 Citations (Scopus)

High efficacy of paclitaxel and doxorubicin as first-line therapy in advanced breast cancer: A phase I-II study

De Lena, M., Latorre, A., Calabrese, P., Catino, A., Lorusso, V., Mazzei, A. & Aloe, A., 2000, In : Journal of Chemotherapy. 12, 4, p. 367-373 7 p.

Research output: Contribution to journalArticle

Maximum Tolerated Dose
Paclitaxel
Doxorubicin
Breast Neoplasms
Neutropenia
1999

Mitoxantrone, l-leucovorin and 5-fluorouracil: An effective and well tolerated first-line treatment for advanced breast cancer

Lorusso, V., Mancarella, S., Catino, A., Brandi, M., Paradiso, A., Latorre, A., Mastria, A., De Mitrio, A., Guida, M. & De Lena, M., Jan 1999, In : Tumori. 85, 1, p. 60-64 5 p.

Research output: Contribution to journalArticle

Mitoxantrone
Leucovorin
Fluorouracil
Breast Neoplasms
Therapeutics
1997
21 Citations (Scopus)

Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum

De Lena, M., Lorusso, V., Bottalico, C., Brandi, M., De Mitrio, A., Catino, A., Guida, M., Latorre, A., Leone, B., Vallejo, C. & Gargano, G., Oct 1997, In : Journal of Clinical Oncology. 15, 10, p. 3208-3213 6 p.

Research output: Contribution to journalArticle

Platinum
Ovarian Neoplasms
Myalgia
lonidamine
Platinum Compounds
3 Citations (Scopus)

Subcutaneous recombinant interleukin-2 plus α interferon and vinblastine in metastatic renal cell carcinoma: A phase II study

Guida, M., Latorre, A., Selvaggi, P. P., Ditonno, P., Lorusso, V., Mastria, A. & De Lena, M., Mar 1997, In : International Journal of Oncology. 10, 3, p. 487-491 5 p.

Research output: Contribution to journalArticle

Vinblastine
Renal Cell Carcinoma
Interferons
Interleukin-2
Pleura
1996
1 Citation (Scopus)

Accelerated neoadjuvant chemotherapy of non-small cell lung cancer (NSCLC)

Lorusso, V., Carpagnano, F., Di Rienzo, G., Catino, A., Cisternino, M. L., Guida, M., Brandi, M., Latorre, A., Parisi, S., Ricco, R. & De Lena, M., Apr 1996, In : International Journal of Oncology. 8, 4, p. 675-680 6 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Drug Therapy
Ifosfamide
Granulocyte Colony-Stimulating Factor
Cisplatin
24 Citations (Scopus)

Subcutaneous Recombinant Interleukin-2 Plus Chemotherapy with Cisplatin and Dacarbazine in Metastatic Melanoma

Guida, M., Latorre, A., Mastria, A. & De Lena, M., Apr 1996, In : European Journal of Cancer. 32, 4, p. 730-733 4 p.

Research output: Contribution to journalArticle

Dacarbazine
Cisplatin
Interleukin-2
Melanoma
Drug Therapy
1995
23 Citations (Scopus)

Long-term subcutaneous recombinant interleukin-2 as maintenance therapy: Biological effects and clinical implications

Guida, M., Abbate, I., Musci, M. D., Casamassima, A., Latorre, A., Lorusso, V., Correale, M. & De Lena, M., 1995, In : Cancer Biotherapy. 10, 3, p. 195-203 9 p.

Research output: Contribution to journalArticle

Biological Therapy
Interleukin-2
Kidney Neoplasms
Therapeutics
Inflammatory Breast Neoplasms
1993
6 Citations (Scopus)

Effects of subcutaneous recombinant IL-2 on humoral immunity in advanced cancer patients

Casamassima, A., Guida, M., Latorre, A., Abbate, I., Triantafillou, V., Musci, M. & De Lena, M., 1993, In : International Journal of Oncology. 3, 2, p. 171-176 6 p.

Research output: Contribution to journalArticle

Humoral Immunity
Interleukin-2
Neoplasms
Lymphocyte Subsets
Renal Cell Carcinoma

Evaluation of phagocytic activity in neoplastic patients treated with subcutaneous recombinant IL-2

Abbate, I., Guida, M., Musci, M. D., Casamassima, A., Latorre, A., Addabbo, L., Dragone, C. D., Cattedra, M., Correale, M. & De Lena, M., 1993, In : International Journal of Oncology. 3, 4, p. 603-606 4 p.

Research output: Contribution to journalArticle

Phagocytosis
Interleukin-2
Granulocytes
Monocytes
Macrophages
1992

INTERLEUCHINA-2: CARATTERISTICHE BIOLOGICHE E POTENZIALITA TERAPEUTICHE IN ONCOLOGIA

Translated title of the contribution: Interleukin-2: Biological characteristics and therapeutic potential in oncologyAddabbo, L., Casamassima, A., Guida, M., Abbate, I., Correale, M., Latorre, A., Mastria, A., Lorusso, V. & De Lena, M., 1992, In : Folia Oncologica. 15, 1, p. 21-26 6 p.

Research output: Contribution to journalArticle

Interleukin-2
Immunotherapy
Melanoma
Immunization
Neoplasms